Keratinocytes determine Th1 immunity during early experimental leishmaniasis

PLoS Pathogens

Volumn 6, Issue 4, 2010, Pages 1-16

  Ehrchen, Jan M ^a   Roebrock, Kirsten ^a   Foell, Dirk ^a   Nippe, Nadine ^a   von Stebut, Esther ^b   Weiss, Johannes M ^c   Münck, Niels Arne ^a   Viemann, Dorothee ^a   Varga, Georg ^a   Müller Tidow, Carsten ^a   Schuberth, Hans Joachim ^d   Roth, Johannes ^a   Sunderkötter, Cord ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c UNIVERSITY OF ULM   (Germany)

^d UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALGRANULIN A; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; OSTEOPONTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; BAGG ALBINO MOUSE; BIOINFORMATICS; C57BL 6 MOUSE; CELL DIFFERENTIATION; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; EPIDERMIS; FEMALE; GENE EXPRESSION; IMMUNOMODULATION; IMMUNOPRECIPITATION; IN SITU HYBRIDIZATION; KERATINOCYTE; LASER MICRODISSECTION; LEISHMANIA MAJOR; MACROPHAGE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; SKIN LEISHMANIASIS; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; UPREGULATION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CYTOLOGY; DISEASE MODEL; DNA MICROARRAY; GENE EXPRESSION PROFILING; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; LASER; MICRODISSECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN; T LYMPHOCYTE SUBPOPULATION;

LEISHMANIA MAJOR; MUS;

ANIMALS; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; GENE EXPRESSION; GENE EXPRESSION PROFILING; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTERLEUKIN-12; INTERLEUKIN-1BETA; INTERLEUKIN-4; INTERLEUKIN-6; KERATINOCYTES; LASERS; LEISHMANIASIS, CUTANEOUS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICRODISSECTION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOPONTIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN; T-LYMPHOCYTE SUBSETS; TH1 CELLS; TH2 CELLS;

EID: 77954037796     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1000871     Document Type: Article

References (65)

1. Sacks D, Noben-Trauth N (2002) The immunology of susceptibility and resistance to Leishmania major in mice. Nat Rev Immunol 2: 845-858.
2. Sunderkotter C, Kunz M, Steinbrink K, Meinardus-Hager G, Goebeler M, et al. (1993) Resistance of mice to experimental leishmaniasis is associated with more rapid appearance of mature macrophages in vitro and in vivo. J Immunol 151: 4891-4901.
3. Tacchini-Cottier F, Zweifel C, Belkaid Y, Mukankundiye C, Vasei M, et al. (2000) An immunomodulatory function for neutrophils during the induction of a CD4+ Th2 response in BALB/c mice infected with Leishmania major. J Immunol 165: 2628-2636.
4. Nabors GS, Nolan T, Croop W, Li J, Farrell JP (1995) The influence of the site of parasite inoculation on the development of Th1 and Th2 type immune responses in (BALB/c6C57BL/6) F1 mice infected with Leishmania major. Parasite Immunol 17: 569-579.
5. Constant SL, Brogdon JL, Piggott DA, Herrick CA, Visintin I, et al. (2002) Resident lung antigen-presenting cells have the capacity to promote Th2 T cell differentiation in situ. J Clin Invest 110: 1441-1448.
6. Kapsenberg ML (2003) Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev Immunol 3: 984-993.
7. Matzinger P (2002) An innate sense of danger. Ann N Y Acad Sci 961: 341-342.
8. Matzinger P (2007) Friendly and dangerous signals: is the tissue in control? Nat Immunol 8: 11-13.
9. Von Stebut E, Ehrchen JM, Belkaid Y, Kostka SL, Molle K, et al. (2003) Interleukin 1alpha promotes Th1 differentiation and inhibits disease progression in Leishmania major-susceptible BALB/c mice. J Exp Med 198: 191-199.
10. Ashkar S, Weber GF, Panoutsakopoulou V, Sanchirico ME, Jansson M, et al. (2000) Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 287: 860-864.
11. Dahlquist KD, Salomonis N, Vranizan K, Lawlor SC, Conklin BR (2002) GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways. Nat Genet 31: 19-20.
12. Doniger SW, Salomonis N, Dahlquist KD, Vranizan K, Lawlor SC, et al. (2003) MAPPFinder: using Gene Ontology and GenMAPP to create a global geneexpression profile from microarray data. Genome Biol 4: R7.
13. Biedermann T, Zimmermann S, Himmelrich H, Gumy A, Egeter O, et al. (2001) IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB/c mice. Nat Immunol 2: 1054-1060.
14. Diehl S, Anguita J, Hoffmeyer A, Zapton T, Ihle JN, et al. (2000) Inhibition of Th1 differentiation by IL-6 is mediated by SOCS1. Immunity 13: 805-815.
15. Rincon M, Anguita J, Nakamura T, Fikrig E, Flavell RA (1997) Interleukin (IL)- 6 directs the differentiation of IL-4-producing CD4+ T cells. J Exp Med 185: 461-469.
16. Ladel CH, Blum C, Dreher A, Reifenberg K, Kopf M, et al. (1997) Lethal tuberculosis in interleukin-6-deficient mutant mice. Infect Immun 65: 4843-4849.
17. Yamamoto M, Yoshizaki K, Kishimoto T, Ito H (2000) IL-6 is required for the development of Th1 cell-mediated murine colitis. J Immunol 164: 4878-4882.
18. Serada S, Fujimoto M, Mihara M, Koike N, Ohsugi Y, Nomura S, Yoshida H, Nishikawa T, Terabe F, Ohkawara T, Takahashi T, Ripley B, Kimura A, Kishimoto T, Naka T (2008) IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A 105: 9041-9046.
19. Sypek JP, Chung CL, Mayor SE, Subramanyam JM, Goldman SJ, Sieburth DS, Wolf SF, Schaub RG (1993) Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J Exp Med 177: 1797-1802.
20. Heinzel FP, Schoenhaut DS, Rerko RM, Rosser LE, Gately MK (1993) Recombinant interleukin 12 cures mice infected with Leishmania major. J Exp Med 177: 1505-1509.
21. Heinzel FP, Rerko RM, Ahmed F, Pearlman E (1995) Endogenous IL-12 is required for control of Th2 cytokine responses capable of exacerbating leishmaniasis in normally resistant mice. J Immunol 155: 730-739.
22. von Stebut E (2007) Cutaneous Leishmania infection: progress in pathogenesis research and experimental therapy. Exp Dermatol 16: 340-346.
23. von Stebut E, Metz M, Milon G, Knop J, Maurer M (2003) Early macrophage influx to sites of cutaneous granuloma formation is dependent on MIP-1alpha/beta released from neutrophils recruited by mast cell-derived TNFalpha. Blood 101: 210-215.
24. Muller K, van ZG, Hansen B, Laufs H, Jahnke N, Solbach W, Laskay T (2001) Chemokines, natural killer cells and granulocytes in the early course of Leishmania major infection in mice. Med Microbiol Immunol 190: 73-76.
25. Vester B, Muller K, Solbach W, Laskay T (1999) Early gene expression of NK cell-activating chemokines in mice resistant to Leishmania major. Infect Immun 67: 3155-3159.
26. Matte C, Olivier M (2002) Leishmania-induced cellular recruitment during the early inflammatory response: modulation of proinflammatory mediators. J Infect Dis 185: 673-681.
27. Antoniazi S, Price HP, Kropf P, Freudenberg MA, Galanos C, Smith DF, Muller I (2004) Chemokine gene expression in toll-like receptor-competent and - deficient mice infected with Leishmania major. Infect Immun 72: 5168-5174.
28. Katzman SD, Fowell DJ (2008) Pathogen-imposed skewing of mouse chemokine and cytokine expression at the infected tissue site. J Clin Invest 118: 801-811.
29. Mbow ML, DeKrey GK, Titus RG (2001) Leishmania major induces differential expression of costimulatory molecules on mouse epidermal cells. Eur J Immunol 31: 1400-1409.
30. Blank C, Fuchs H, Rappersberger K, Rollinghoff M, Moll H (1993) Parasitism of epidermal Langerhans cells in experimental cutaneous leishmaniasis with Leishmania major. J Infect Dis 167: 418-425.
31. Moll H, Flohe S, Rollinghoff M (1995) Dendritic cells in Leishmania majorimmune mice harbor persistent parasites and mediate an antigen-specific T cell immune response. Eur J Immunol 25: 693-699.
32. Will A, Blank C, Rollinghoff M, Moll H (1992) Murine epidermal Langerhans cells are potent stimulators of an antigen-specific T cell response to Leishmania major, the cause of cutaneous leishmaniasis. Eur J Immunol 22: 1341-1347.
33. Chaussabel D, Semnani RT, McDowell MA, Sacks D, Sher A, Nutman TB (2003) Unique gene expression profiles of human macrophages and dendritic cells to phylogenetically distinct parasites. Blood 102: 672-681.
34. Racoosin EL, Beverley SM (1997) Leishmania major: promastigotes induce expression of a subset of chemokine genes in murine macrophages. Exp Parasitol 85: 283-295.
35. Badolato R, Sacks DL, Savoia D, Musso T (1996) Leishmania major: infection of human monocytes induces expression of IL-8 and MCAF. Exp Parasitol 82: 21-26.
36. Cillari E, Dieli M, Maltese E, Milano S, Salerno A, Liew FY (1989) Enhancement of macrophage IL-1 production by Leishmania major infection in vitro and its inhibition by IFN-gamma. J Immunol 143: 2001-2005.
37. van Zandbergen G, Klinger M, Mueller A, Dannenberg S, Gebert A, Solbach W, Laskay T (2004) Cutting edge: neutrophil granulocyte serves as a vector for Leishmania entry into macrophages. J Immunol 173: 6521-6525.
38. van Zandbergen G, Hermann N, Laufs H, Solbach W, Laskay T (2002) Leishmania promastigotes release a granulocyte chemotactic factor and induce interleukin-8 release but inhibit gamma interferon-inducible protein 10 production by neutrophil granulocytes. Infect Immun 70: 4177-4184.
39. Albanesi C, Scarponi C, Giustizieri ML, Girolomoni G (2005) Keratinocytes in inflammatory skin diseases. Curr Drug Targets Inflamm Allergy 4: 329-334.
40. Lopez KS, Dinges S, Griewank K, Iwakura Y, Udey MC, von Stebut E (2009) IL-17 promotes progression of cutaneous leishmaniasis in susceptible mice. J Immunol 182: 3039-3046.
41. Renkl AC, Wussler J, Ahrens T, Thoma K, Kon S, Uede T, Martin SF, Simon JC, Weiss JM (2005) Osteopontin functionally activates dendritic cells and induces their differentiation toward a Th1-polarizing phenotype. Blood 106: 946-955.
42. Filippi C, Hugues S, Cazareth J, Julia V, Glaichenhaus N, Ugolini S (2003) CD4+ T cell polarization in mice is modulated by strain-specific major histocompatibility complex-independent differences within dendritic cells. J Exp Med 198: 201-209.
43. Launois P, Ohteki T, Swihart K, MacDonald HR, Louis JA (1995) In susceptible mice, Leishmania major induce very rapid interleukin-4 production by CD4+ T cells which are NK1.1-. Eur J Immunol 25: 3298-3307.
44. Launois P, Maillard I, Pingel S, Swihart KG, Xenarios I, Acha-Orbea H, Diggelmann H, Locksley RM, MacDonald HR, Louis JA (1997) IL-4 rapidly produced by V beta 4 V alpha 8 CD4+ T cells instructs Th2 development and susceptibility to Leishmania major in BALB/c mice. Immunity 6: 541-549.
45. Himmelrich H, Launois P, Maillard I, Biedermann T, Tacchini-Cottier F, Locksley RM, Rocken M, Louis JA (2000) In BALB/c mice, IL-4 productionduring the initial phase of infection with Leishmania major is necessary and sufficient to instruct Th2 cell development resulting in progressive disease. J Immunol 164: 4819-4825.
46. Hochrein H, O'Keeffe M, Luft T, Vandenabeele S, Grumont RJ, Maraskovsky E, Shortman K (2000) Interleukin (IL)-4 is a major regulatory cytokine governing bioactive IL-12 production by mouse and human dendritic cells. J Exp Med 192: 823-833.
47. Nigg AP, Zahn S, Ruckerl D, Holscher C, Yoshimoto T, Ehrchen JM, Wolbing F, Udey MC, von Stebut E (2007) Dendritic cell-derived IL-12p40 homodimer contributes to susceptibility in cutaneous leishmaniasis in BALB/c mice. J Immunol 178: 7251-7258.
48. Korn T, Mitsdoerffer M, Croxford AL, Awasthi A, Dardalhon VA, Galileos G, Vollmar P, Stritesky GL, Kaplan MH, Waisman A, Kuchroo VK, Oukka M (2008) IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells. Proc Natl Acad Sci U S A 105: 18460-18465.
49. Liang S, Ristich V, Arase H, Dausset J, Carosella ED, Horuzsko A (2008) Modulation of dendritic cell differentiation by HLA-G and ILT4 requires the IL-6-STAT3 signaling pathway. Proc Natl Acad Sci U S A 105: 8357-8362.
50. Kitamura H, Kamon H, Sawa S, Park SJ, Katunuma N, Ishihara K, Murakami M, Hirano T (2005) IL-6-STAT3 controls intracellular MHC class II alphabeta dimer level through cathepsin S activity in dendritic cells. Immunity 23: 491-502.
51. Chomarat P, Banchereau J, Davoust J, Palucka AK (2000) IL-6 switches the differentiation of monocytes from dendritic cells to macrophages. Nat Immunol 1: 510-514.
52. Takenaka H, Maruo S, Yamamoto N, Wysocka M, Ono S, Kobayashi M, Yagita H, Okumura K, Hamaoka T, Trinchieri G, Fujiwara H (1997) Regulation of T cell-dependent and -independent IL-12 production by the three Th2-type cytokines IL-10, IL-6, and IL-4. J Leukoc Biol 61: 80-87.
53. Moskowitz NH, Brown DR, Reiner SL (1997) Efficient immunity against Leishmania major in the absence of interleukin-6. Infect Immun 65: 2448-2450.
54. Titus RG, DeKrey GK, Morris RV, Soares MB (2001) Interleukin-6 deficiency influences cytokine expression in susceptible BALB mice infected with Leishmania major but does not alter the outcome of disease. Infect Immun 69: 5189-5192.
55. Anderson CF, Oukka M, Kuchroo VJ, Sacks D (2007) CD4(+)CD25(2) Foxp3(2) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J Exp Med %19;204: 285-297.
56. Suffia IJ, Reckling SK, Piccirillo CA, Goldszmid RS, Belkaid Y (2006) Infected site-restricted Foxp3+ natural regulatory T cells are specific for microbial antigens. J Exp Med %20;203: 777-788.
57. Belkaid Y (2003) The role of CD4(+)CD25(+) regulatory T cells in Leishmania infection. Expert Opin Biol Ther 3: 875-885.
58. Belkaid Y, Piccirillo CA, Mendez S, Shevach EM, Sacks DL (2002) CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 420: 502-507.
59. Aseffa A, Gumy A, Launois P, MacDonald HR, Louis JA, Tacchini-Cottier F (2002) The early IL-4 response to Leishmania major and the resulting Th2 cell maturation steering progressive disease in BALB/c mice are subject to the control of regulatory CD4+CD25+ T cells. J Immunol 169: 3232-3241.
60. Ehrchen J, Steinmuller L, Barczyk K, Tenbrock K, Nacken W, Eisenacher M, Nordhues U, Sorg C, Sunderkotter C, Roth J (2007) Glucocorticoids induce differentiation of a specifically activated, anti-inflammatory subtype of human monocytes. Blood 109: 1265-1274.
61. Viemann D, Schmidt M, Tenbrock K, Schmid S, Muller V, Klimmek K, Ludwig S, Roth J, Goebeler M (2007) The contact allergen nickel triggers a unique inflammatory and proangiogenic gene expression pattern via activation of NF-kappaB and hypoxia-inducible factor-1alpha. J Immunol 178: 3198-3207.
62. Ehrchen J, Heuer H, Sigmund R, Schafer MK, Bauer K (2001) Expression and regulation of osteopontin and connective tissue growth factor transcripts in rat anterior pituitary. J Endocrinol 169: 87-96.
63. Westphal G, Burgemeister R, Friedemann G, Wellmann A, Wernert N, Wollscheid V, Becker B, Vogt T, Knuchel R, Stolz W, Schutze K (2002) Noncontact laser catapulting: a basic procedure for functional genomics and proteomics. Methods Enzymol 356: 80-99.
64. Ehrchen J, Helming L, Varga G, Pasche B, Loser K, Gunzer M, Sunderkotter C, Sorg C, Roth J, Lengeling A (2007) Vitamin D receptor signaling contributes to susceptibility to infection with Leishmania major. FASEB J 21: 3208-3218.
65. Ehrchen JM, Roth J, Roebrock K, Varga G, Domschke W, Newberry R, Sorg C, Muller-Tidow C, Sunderkotter C, Kucharzik T, Spahn TW (2008) The absence of cutaneous lymph nodes results in a Th2 response and increased susceptibility to Leishmania major infection in mice. Infect Immun 76: 4241-4250.